A citation-based method for searching scientific literature

Annette Haacke, Sarah A Broadley, Raina Boteva, Nikolay Tzvetkov, F Ulrich Hartl, Peter Breuer. Hum Mol Genet 2006
Times Cited: 93



Laura Masino, Giuseppe Nicastro, Rajesh P Menon, Fabrizio Dal Piaz, Lesley Calder, Annalisa Pastore. J Mol Biol 2004
Times Cited: 98




List of shared articles



Times cited



Conformational diseases: structural studies of aggregation of polyglutamine proteins.
Elena Papaleo, Gaetano Invernizzi. Curr Comput Aided Drug Des 2011
10

N-terminal ataxin-3 causes neurological symptoms with inclusions, endoplasmic reticulum stress and ribosomal dislocation.
Jeannette Hübener, Franz Vauti, Claudia Funke, Hartwig Wolburg, Yihong Ye, Thorsten Schmidt, Karen Wolburg-Buchholz, Ina Schmitt, Adriane Gardyan, Stefan Driessen,[...]. Brain 2011
38

Identification and functional dissection of localization signals within ataxin-3.
Paul Michel Aloyse Antony, Simone Mäntele, Phillip Mollenkopf, Jana Boy, Ralph H Kehlenbach, Olaf Riess, Thorsten Schmidt. Neurobiol Dis 2009
33


Chaperones in Polyglutamine Aggregation: Beyond the Q-Stretch.
E F E Kuiper, Eduardo P de Mattos, Laura B Jardim, Harm H Kampinga, Steven Bergink. Front Neurosci 2017
23

Conformational behavior and aggregation of ataxin-3 in SDS.
Helen M Saunders, Victoria A Hughes, Roberto Cappai, Stephen P Bottomley. PLoS One 2013
6


Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease.
Carlos A Matos, Sandra de Macedo-Ribeiro, Ana Luísa Carvalho. Prog Neurobiol 2011
89

Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies.
Melvin M Evers, Lodewijk J A Toonen, Willeke M C van Roon-Mom. Mol Neurobiol 2014
48

The structural impact of a polyglutamine tract is location-dependent.
Amy L Robertson, James Horne, Andrew M Ellisdon, Bronwen Thomas, Martin J Scanlon, Stephen P Bottomley. Biophys J 2008
28


Proteolytic Cleavage of Polyglutamine Disease-Causing Proteins: Revisiting the Toxic Fragment Hypothesis.
Carlos A Matos, Luis Pereira de Almeida, Clevio Nobrega. Curr Pharm Des 2017
16